Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    ACTRIMS 2023
    ISC 2023
    EHC 2022
    AES 2022
    WSC 2022
    ECTRIMS 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Jaume Sastre-Garriga

OCT measures association with serum/CSF biomarkers in CIS patients 2:00
OCT measures association with serum/CSF biomarkers in CIS patients
Jaume Sastre-Garriga • 28 Oct 2022
Upcoming MRI biomarkers in multiple sclerosis 1:09
Upcoming MRI biomarkers in multiple sclerosis
Jaume Sastre-Garriga • 28 Oct 2022
Reappraisal of the 2017 McDonald criteria for multiple sclerosis 3:00
Reappraisal of the 2017 McDonald criteria for multiple sclerosis
Jaume Sastre-Garriga • 28 Oct 2022
Implementation of novel imaging biomarkers in clinical practice 1:52
Implementation of novel imaging biomarkers in clinical practice
Jaume Sastre-Garriga • 28 Oct 2022
Spinal cord reserve: validation of SCaA-SCT in a prospective cohort of MS patients 2:35
Spinal cord reserve: validation of SCaA-SCT in a prospective cohort of MS patients
Jaume Sastre-Garriga • 28 Oct 2022
The timing and choice of DMTs for MS patients 3:06
The timing and choice of DMTs for MS patients
Jaume Sastre-Garriga • 28 Oct 2022
Defining spinal cord reserve and its correlation with disability in MS 4:16
Defining spinal cord reserve and its correlation with disability in MS
Jaume Sastre-Garriga • 3 Apr 2022
Developments in utilizing MRI biomarkers in MS 3:07
Developments in utilizing MRI biomarkers in MS
Jaume Sastre-Garriga • 3 Apr 2022
Utility of brain volumetry and tissue integrity in MS diagnosis 2:29
Utility of brain volumetry and tissue integrity in MS diagnosis
Jaume Sastre-Garriga • 3 Apr 2022
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy